TTE.US
60.24
+1.19%↑
EQNR.US
25.19
-0.16%↓
KMI
28.04
-0.71%↓
SLB
33.52
+1.92%↑
E
34.25
+1.06%↑
TTE.US
60.24
+1.19%↑
EQNR.US
25.19
-0.16%↓
KMI
28.04
-0.71%↓
SLB
33.52
+1.92%↑
E
34.25
+1.06%↑
TTE.US
60.24
+1.19%↑
EQNR.US
25.19
-0.16%↓
KMI
28.04
-0.71%↓
SLB
33.52
+1.92%↑
E
34.25
+1.06%↑
TTE.US
60.24
+1.19%↑
EQNR.US
25.19
-0.16%↓
KMI
28.04
-0.71%↓
SLB
33.52
+1.92%↑
E
34.25
+1.06%↑
TTE.US
60.24
+1.19%↑
EQNR.US
25.19
-0.16%↓
KMI
28.04
-0.71%↓
SLB
33.52
+1.92%↑
E
34.25
+1.06%↑
24h
Praegune
Min
75.46
Max
79.86
Sissetulek | -100M -69M |
---|---|
Müük | 448M 1B |
P/E Sektori keskmine | 15.515 35.126 |
Aktsiakasum | -0.17 |
Dividenditootlus | 0.77 |
Kasumimarginaal | -6.809 |
Töötajad | 2,076 |
EBITDA | -41M 56M |
Soovitused | Tugev "osta" hinnang |
---|---|
12 kuu keskmine prognoos | +26.32% upside |
Dividenditootlus Sektori keskmine | 0.77% 5.63% |
---|---|
Järgmine tulemuste avaldamine | 5. aug 2025 |
Järgmine dividendimakse kuupäev | 12. sept 2025 |
Järgmine aktsia dividendi kuupäev (ex-date) | 29. aug 2025 |
Turukapital | -3.3M 4B |
---|---|
Eelmine avamishind | 74.73 |
Eelmine sulgemishind | 78.58 |
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
4. aug 2025, 21:42 UTC
Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone
DJ
Loe
4. aug 2025, 21:21 UTC
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update
DJ
Loe
4. aug 2025, 20:45 UTC
Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb
DJ
Loe
4. aug 2025, 19:15 UTC
TransMedics Group Shares Rise on FDA Approval for Clinical Trial
DJ
Loe
4. aug 2025, 23:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Loe
4. aug 2025, 23:41 UTC
Nikkei May Rise on Fed Stimulus Hopes
DJ
Loe
4. aug 2025, 23:28 UTC
Global Equities Roundup: Market Talk
DJ
Loe
4. aug 2025, 23:28 UTC
Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk
DJ
Loe
4. aug 2025, 21:30 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Loe
4. aug 2025, 21:21 UTC
Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com
DJ
Loe
4. aug 2025, 21:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Loe
4. aug 2025, 20:25 UTC
India Hits Back Over Russian Oil Purchases -- Market Talk
DJ
Loe
4. aug 2025, 20:25 UTC
Transocean 2Q Loss $938M >RIG
DJ
Loe
4. aug 2025, 20:25 UTC
Transocean 2Q Loss/Shr $1.06 >RIG
DJ
Loe
4. aug 2025, 20:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com
DJ
Loe
4. aug 2025, 20:15 UTC
Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX
DJ
Loe
4. aug 2025, 20:14 UTC
Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX
DJ
Loe
4. aug 2025, 20:14 UTC
Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX
DJ
Loe
4. aug 2025, 20:14 UTC
Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX
DJ
Loe
4. aug 2025, 20:13 UTC
Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX
DJ
Loe
4. aug 2025, 20:09 UTC
Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM
DJ
Loe
4. aug 2025, 20:06 UTC
Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com
DJ
Loe
4. aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Net $1.03B >VRTX
DJ
Loe
4. aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX
DJ
Loe
4. aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX
DJ
Loe
4. aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX
DJ
Loe
4. aug 2025, 19:41 UTC
U.S. Natural Gas Futures Settle Lower -- Market Talk
DJ
Loe
4. aug 2025, 19:28 UTC
U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk
DJ
Loe
4. aug 2025, 19:07 UTC
Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk
DJ
Loe
4. aug 2025, 18:27 UTC
Gold Climbs on Rate Cut Speculation -- Market Talk
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 92 USD 26.32%
Kõrge 110 USD
Madal 75 USD
Põhineb 4 Wall Streeti analüütiku instrumendi Core Natural Resources Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Tugev "osta" hinnang
4 ratings
3
Osta
1
Hoia
0
Müü
Põhineb 4 analüütiku instrumendi Core Natural Resources Inc aktsia reitingul - viimase 3 kuu andmed.
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$